Healthcare5 months ago
Lupin Limited (lupin) Secures EMA Approval for Expanded Pediatric Indication for Namuscla®
Lupin Limited (LUPIN) secures EMA approval for expanded pediatric indication for NaMuscla®, broadening access to treatment for non-dystrophic myotonic disord.